SEC Form 4 · accession 0001161697-15-000446
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Douglas Winship
Officer — VP, Regulatory Operations
Period of report
Oct 23, 2015
Accepted (ET)
Oct 23, 2015 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1 | Oct 23, 2015 | S | 22,800 | $3.34 | D | 74,131 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold principally for the purpose of funding the exercise of stock options that will expire in November 2015. The exercise of the stock options using the proceeds of this sale will be reported in a separate Form 4.